Clinical Trial

PI-YSP-0111 Formulation on Human Gut Microbiota and Body Composition

Name: PI-YSP-0111 Formulation on Human Gut Microbiota and Body Composition — clinical trial record (NCT07618000)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The expected outcome of this study is that continuous 8-week supplementation with the PI-YSP-0111 prebiotic formulation will exert beneficial effects on gut microbiota modulation and liver health.

Trial Details

NCT Number	NCT07618000
Lead Sponsor	Taipei Medical University Collaborators: Yung Shin Pharm. Ind. Co., Ltd.
Conditions	Heathly Volunteers
Enrollment	140 participants
Start Date	2026-04-08
Primary Completion	2027-04-07 (estimated)
Study Completion	2027-04-07 (estimated)
Updated on ClinicalTrials.gov	2026-06-01